A Multicenter, Randomized, Double-Blind, Controlled Study of EXPAREL for Postsurgical Pain Management in Subjects Undergoing Open Lumbar Spinal Fusion Surgery
Phase of Trial: Phase IV
Latest Information Update: 15 Dec 2017
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Pharmacokinetics
- Sponsors Pacira Pharmaceuticals
- 07 Dec 2017 Status changed from recruiting to discontinued due to slow enrollment.
- 20 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Sep 2017.
- 20 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Sep 2017.